Associations between the HLA-A/B/DRB1 polymorphisms and aplastic anemia: evidence from 17 case–control studies

References

• Rehman S, Saba N, Khalilullah Munir S, et al. The frequency of HLA class I and II alleles in Pakistani patients with aplastic anemia. Immunol Invest. 2009;38(8):812–819. DOI:10.3109/08820130903271415.
   PubMed Web of Science ®Google Scholar
• Wang M, Nie N, Feng S, et al. The polymorphisms of human leukocyte antigen loci may contribute to the susceptibility and severity of severe aplastic anemia in Chinese patients. Hum Immunol. 2014;75(8):867–872. DOI:10.1016/j.humimm.2014.06.011.
   PubMed Web of Science ®Google Scholar
• Benitez-Aranda H, Velez-Ruelas MA, Diaz-Cardenas S, et al. Incidence of aplastic anemia in a defined subpopulation from Mexico city. Hematology. 2002;7(4):229–232. DOI:10.1080/1024533021000024085.
   PubMedGoogle Scholar
• Marsh JC, Ball SE, Darbyshire P, et al. Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol. 2003;123(5):782–801. doi: 10.1046/j.1365-2141.2003.04721.x
   PubMed Web of Science ®Google Scholar
• Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 2006;108(8):2509–2519. DOI:10.1182/blood-2006-03-010777.
   PubMed Web of Science ®Google Scholar
• Shao W, Tian D, Liu C, et al. Aplastic anemia is associated with HLA-DRB1*1501 in northern Han Chinese. Int J Hematol. 2000;71(4):350–352.
   PubMed Web of Science ®Google Scholar
• Kordasti S, Marsh J, Al-Khan S, et al. Functional characterization of CD4+ T cells in aplastic anemia. Blood. 2012;119(9):2033–2043. DOI:10.1182/blood-2011-08-368308.
   PubMed Web of Science ®Google Scholar
• Yari F, Sobhani M, Vaziri MZ, et al. Association of aplastic anaemia and Fanconi's disease with HLA-DRB1 alleles. Int J Immunogenet. 2008;35(6):453–456. DOI:10.1111/j.1744-313X.2008.00810.x.
   PubMed Web of Science ®Google Scholar
• Hughes AL, Nei M. Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection. Nature. 1988;335(6186):167–170. doi:10.1038/335167a0.
   PubMed Web of Science ®Google Scholar
• Hughes AL, Nei M. Nucleotide substitution at major histocompatibility complex class II loci: evidence for overdominant selection. Proc Natl Acad Sci USA. 1989;86(3):958–962. doi: 10.1073/pnas.86.3.958
   PubMed Web of Science ®Google Scholar
• Complete Sequence and Gene Map of a Human Major Histocompatibility Complex. The MHC sequencing consortium. Nature. 1999;401(6756):921–923. DOI:10.1038/44853.
   PubMedGoogle Scholar
• Schultz JC, Shahidi NT. Detection of tumor necrosis factor-alpha in bone marrow plasma and peripheral blood plasma from patients with aplastic anemia. Am J Hematol. 1994;45(1):32–38. doi: 10.1002/ajh.2830450106
   PubMed Web of Science ®Google Scholar
• Shichishima T, Noji H, Ikeda K, et al. The frequency of HLA class I alleles in Japanese patients with bone marrow failure. Haematologica. 2006;91(6):856–857.
   PubMed Web of Science ®Google Scholar
• Kapustin SI, Popova TI, Lyshchov AA, et al. HLA-DR4-Ala74 beta is associated with risk and poor outcome of severe aplastic anemia. Ann Hematol. 2001;80(2):66–71. doi: 10.1007/s002770000234
   PubMed Web of Science ®Google Scholar
• Young NS, Scheinberg P, Calado RT. Aplastic anemia. Curr Opin Hematol. 2008;15(3):162–168. DOI:10.1097/MOH.0b013e3282fa7470.
   PubMed Web of Science ®Google Scholar
• Sugimori C, Yamazaki H, Feng X, et al. Roles of DRB1 *1501 and DRB1 *1502 in the pathogenesis of aplastic anemia. Exp Hematol. 2007;35(1):13–20. DOI:10.1016/j.exphem.2006.09.002.
   PubMed Web of Science ®Google Scholar
• Liu S, Li Q, Zhang Y, et al. Association of human leukocyte antigen DRB1*15 and DRB1*15:01 polymorphisms with response to immunosuppressive therapy in patients with aplastic anemia: a meta-analysis. PLoS One. 2016;11(9):e0162382. DOI:10.1371/journal.pone.0162382.
   PubMed Web of Science ®Google Scholar
• Song EY, Park S, Lee DS, et al. Association of human leukocyte antigen-DRB1 alleles with disease susceptibility and severity of aplastic anemia in Korean patients. Hum Immunol. 2008;69(6):354–359. DOI:10.1016/j.humimm.2008.04.009.
   PubMed Web of Science ®Google Scholar
• Huo MR, Yu Y, Liu HY, et al. Association of HLA DRB1 polymorphism with susceptibility to myelodysplastic syndrome and aplastic anemia in Chinese Han population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011;28(3):296–299. DOI:10.3760/cma.j.issn.1003-9406.2011.03.013.
   PubMedGoogle Scholar
• Dhaliwal JS, Wong L, Kamaluddin MA, et al. Susceptibility to aplastic anemia is associated with HLA-DRB1*1501 in an aboriginal population in Sabah, Malaysia. Hum Immunol. 2011;72(10):889–892. DOI:10.1016/j.humimm.2011.06.013.
   PubMed Web of Science ®Google Scholar
• Liang XL, Qiu LG, Sun LJ, et al. Correlation of HLA-alleles with aplastic anemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007;15(6):1208–1211.
   PubMedGoogle Scholar
• Chapuis B, Von Fliedner VE, Jeannet M, et al. Increased frequency of DR2 in patients with aplastic anaemia and increased DR sharing in their parents. Br J Haematol. 1986;63(1):51–57. doi: 10.1111/j.1365-2141.1986.tb07494.x
   PubMed Web of Science ®Google Scholar
• Sun W, Zhao S. Study on the association of TCM syndrome differentiation of chronic aplastic anemia and HLA gene. China J Tradit Chin Med Pharm. 2002;1:167–169.
   Google Scholar
• Albert E, Thomas ED, Nisperos B, et al. HLA antigens and haplotypes in 200 patients with aplastic anemia. Transplantation. 1976;22(5):528–531. doi: 10.1097/00007890-197611000-00020
   PubMed Web of Science ®Google Scholar
• Fernandez-Torres J, Flores-Jimenez D, Arroyo-Perez A, et al. The ancestry of the HLA-DRB1*15 allele predisposes the Mexican mestizo to the development of aplastic anemia. Hum Immunol. 2012;73(8):840–843. DOI:10.1016/j.humimm.2012.04.012.
   PubMed Web of Science ®Google Scholar
• Chen C, Lu S, Luo M, et al. Correlations between HLA-A, HLA-B and HLA-DRB1 allele polymorphisms and childhood susceptibility to acquired aplastic anemia. Acta Haematol. 2012;128(1):23–27. DOI:10.1159/000337094.
   PubMed Web of Science ®Google Scholar
• Fuhrer M, Durner J, Brunnler G, et al. HLA association is different in children and adults with severe acquired aplastic anemia. Pediatr Blood Cancer. 2007;48(2):186–191. DOI:10.1002/pbc.20785.
   PubMed Web of Science ®Google Scholar
• Oguz FS, Yalman N, Diler AS, et al. HLA-DRB1*15 and pediatric aplastic anemia. Haematologica. 2002;87(7):772–774.
   PubMed Web of Science ®Google Scholar
• Yin S, Ma W, Zhu W, et al. Immunogenetic association of HLA class I, II with aplastic anemia in Chinese population. Med J Chin People's Armed Police Forces. 1997;5:255–256.
   Google Scholar
• Camitta B. M, Store R, Thomas E. D. Aplastic anemia. Pathogenesis, diagnosis, treatment and prognosis. N Engl J Med. 1982;306:645–652. doi: 10.1056/NEJM198203183061105
   PubMed Web of Science ®Google Scholar
• Li J, Jia G, Liu X. Advances in the pathogenesis of aplastic anemia. Chin J Lab Diagnosis. 2017;21(1):165–168.
   Google Scholar
• Aggarwal S, Pittenger MF. Human mesenchymal stem celts rood ulate allogeneic immune responses. Blood. 2005;i05(4):1815. doi: 10.1182/blood-2004-04-1559
   Web of Science ®Google Scholar
• Zhao L, Xiao Y, Jin R. The progress of pathogenesis of aplastic anemia. Chin J Pract Pediatr. 2011;18(7):545–548.
   Google Scholar
• Liu C, Li Z, Sheng W, et al. Abnormalities of quantities and functions of natural killer cells in severe aplastic anemia. Immunol Invest. 2014;43(5):491–503. DOI:10.3109/08820139.2014.888448.
   PubMed Web of Science ®Google Scholar
• Wang T, Mei SC, Fu R, et al. Expression of shelter in component POT1 is associated with decreased telomere length and immunity condition in humans with severe aplastic anemia. Res J Immunol. 2013;2014(2014):439530.
   Google Scholar
• Usman M, Adil SN, Moatter T, et al. Increased expression of HLA DR2 in acquired aplastic anemia and its impact on response to immunosuppressive therapy. J Pak Med Assoc. 2004;54(5):251–254.
   PubMedGoogle Scholar
• Saunthararajah Y, Nakamura R, Nam JM, et al. HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood. 2002;100(5):1570–1574.
   PubMed Web of Science ®Google Scholar
• Lu SY, Xiao LL, Luo M, et al. Relationship between polymorphism of HLA-A, -B, -DRB1 alleles and susceptibility of children to acquired aplastic anemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012;20(1):120–124.
   PubMedGoogle Scholar